Filter Results:
(2,286)
Show Results For
- All HBS Web
(2,286)
- News (376)
- Research (1,621)
- Events (19)
- Multimedia (25)
- Faculty Publications (947)
Show Results For
- All HBS Web
(2,286)
- News (376)
- Research (1,621)
- Events (19)
- Multimedia (25)
- Faculty Publications (947)
- August 2010
- Article
Sell-Side School Ties
By: Lauren H. Cohen, Christopher J. Malloy and Andrea Frazzini
We study the impact of social networks on agents' ability to gather superior information about firms. Exploiting novel data on the educational backgrounds of sell-side equity analysts and senior officers of firms, we test the hypothesis that analysts' school ties to... View Details
Keywords: Investment Return; Investment Portfolio; Corporate Disclosure; Governing Rules, Regulations, and Reforms; Knowledge Acquisition; Social and Collaborative Networks
Cohen, Lauren H., Christopher J. Malloy, and Andrea Frazzini. "Sell-Side School Ties." Journal of Finance 65, no. 4 (August 2010): 1409–1437. (Winner of Smith Breeden Prize for the Best Paper Published in the Journal of Finance in Asset Pricing (Distinguished Paper) 2010.)
- 23 Jun 2015
- News
Governance reforms add significance to being a public company
- 27 Mar 2018
- First Look
First Look at New Research, March 27, 2018
forthcoming Harvard Journal on Legislation From the Digital to the Physical: Federal Limitations on Regulating Online Marketplaces By: Edelman, Benjamin, and Abbey Stemler Abstract—Online marketplaces have transformed how we shop, travel,... View Details
Keywords: Sean Silverthorne
- September 2022
- Article
Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities
By: Leemore Dafny, Christopher Ody and Teresa Rokos
The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees’ out-of-pocket spending for the drugs they manufacture, but manufacturers may donate to independent patient assistance charities and earmark donations... View Details
Keywords: Cost Sharing; Prescription Drugs; Drug Spending; Medicare; Dual Eligibility; Cost; Health Care and Treatment; Philanthropy and Charitable Giving; Pharmaceutical Industry
Dafny, Leemore, Christopher Ody, and Teresa Rokos. "Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities." Health Affairs 41, no. 9 (September 2022).
- March 2011 (Revised March 2011)
- Case
Horizon Blue Cross Blue Shield of New Jersey - Managing in the Shadow of Health Care Reform
Per the Patient Protection and Affordable Care Act (PPACA), which President Obama signed in 2010, states would be required to create state-wide health insurance marketplaces - the Health Benefit Exchanges (HBEs) - in which individuals and small employers could choose... View Details
Keywords: Insurance; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Emerging Markets; Risk and Uncertainty; Health Industry; Insurance Industry; New Jersey
Oberholzer-Gee, Felix, Raffaella Sadun, and Richard G. Hamermesh. "Horizon Blue Cross Blue Shield of New Jersey - Managing in the Shadow of Health Care Reform." Harvard Business School Case 711-403, March 2011. (Revised March 2011.)
- November 2007
- Class Lecture
The Baby Business (FSS)
By: Debora L. Spar
In vitro fertilization and genetic screening are possible with the advent of biotechnology. International adoptions, surrogacy, and other approaches to family planning are on the rise. But few rules govern these measures, medical costs can be prohibitive, and... View Details
Keywords: Governing Rules, Regulations, and Reforms; Policy; Demand and Consumers; Business and Government Relations; Business and Stakeholder Relations; Genetics; Societal Protocols; Commercialization; Biotechnology Industry; Health Industry
Spar, Debora L. "The Baby Business (FSS)." Harvard Business School Class Lecture 708-701, November 2007.
- January 1993 (Revised November 1995)
- Case
AXA: The Global Insurance Company
Claude Bebear, the CEO of AXA, the tenth-largest insurer in Europe, has just completed an acquisition of the Equitable, the seventh-largest insurer in the United States. As part of his strategy to make AXA the first truly global insurance company, Bebear is considering... View Details
Keywords: Market Entry and Exit; Insurance; Global Strategy; Acquisition; Insurance Industry; Asia; North America; Europe
Goodman, John B., and Patrick Moreton. "AXA: The Global Insurance Company." Harvard Business School Case 793-094, January 1993. (Revised November 1995.)
- 12 Nov 2014
- News
Whalen: Dow Should Give Money Back to Shareholders
- 06 Jan 2016
- Video
A Microchip in Your Medicine
- 25 Feb 2015
- Working Paper Summaries
Thick as Thieves? Dishonest Behavior and Egocentric Social Networks
- 03 Dec 2009
- News
How to take moral hazard out of banking
- 23 Mar 2021
- News
Should Gig Work Be Government-Run?
- March 2014
- Teaching Note
E-Cigarettes: Marketing Versus Public Health
By: John A. Quelch
Electronic cigarettes (e-cigarettes) were heralded by some as a healthcare game changer, enabling smokers to switch to a new product which carried lower risk of cancer. However, there were concerns about the public health risk of e-cigarettes, particularly the chance... View Details
- 08 Sep 2016
- Video